Visit-to-visit Blood Pressure Variability and Arterial Stiffness: Which Came First: The Chicken or the Egg?

Author(s): Shunsuke Miyauchi, Michiaki Nagai*, Keigo Dote, Masaya Kato, Noboru Oda, Eiji Kunita, Eisuke Kagawa, Aya Yamane, Tasuku Higashihara, Arinori Takeuchi, Akane Tsuchiya, Kosuke Takahari

Journal Name: Current Pharmaceutical Design

Volume 25 , Issue 6 , 2019

Become EABM
Become Reviewer

Abstract:

Earlier studies have shown that visit-to-visit blood pressure (BP) variability (VVV) served as a significant independent risk factor of stroke, specifically, in the high-risk elderly of cardiovascular disease (CVD). Although the mechanism is not clearly understood, arterial remodeling such as carotid artery, coronary artery and large aortic artery would be a strong moderator in the relationship between VVV and CVD incidence. Recent studies have provided evidence that VVV predicted the progression of arterial stiffness. While the class of antihypertensive agents is suggested to be an important determinant of VVV, long-acting calcium channel blockers use (CCBs) is associated with the reduction of VVV, and thus, is suggested to decrease the arterial stiffness. Specifically, the relationship between VVV and coronary arterial remodeling has never been reviewed until now. This article summarizes the recent literature on these topics. In the elderly hypertensives, strict BP control using CCBs could play a pivotal role in suppressing arterial stiffening via VVV reduction.

Keywords: Hypertension, visit-to-visit blood pressure variability, artery remodeling, arterial stiffness, intima-media thickness, coronary artery.

[1]
AHA. Heart Disease and Stroke Statistics - Update. 2005.
[2]
Rothwell PM, Howard SC, Dolan E, et al. Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension. Lancet 2010; 375(9718): 895-905.
[3]
Nagai M, Dote K, Kato M, et al. Visit-to-visit blood pressure variability and classes of antihypertensive agents; associations with artery remodeling and the risk of stroke. Curr Pharm Des 2016; 22(3): 383-9.
[4]
Webb AJ, Fischer U, Mehta Z, Rothwell PM. Effects of antihypertensive-drug class on interindividual variation in blood pressure and risk of stroke: A systematic review and meta-analysis. Lancet 2010; 375(9718): 906-15.
[5]
Okada H, Fukui M, Tanaka M, et al. Visit-to-visit variability in systolic blood pressure is correlated with diabetic nephropathy and atherosclerosis in patients with type 2 diabetes. Atherosclerosis 2012; 220(1): 155-9.
[6]
Diaz KM, Veerabhadrappa P, Kashem MA, et al. Relationship of visit-to-visit and ambulatory blood pressure variability to vascular function in African Americans. Hypertens Res 2012; 35(1): 55-61.
[7]
Schillaci G, Bilo G, Pucci G, et al. Relationship between short-term blood pressure variability and large-artery stiffness in human hypertension: findings from 2 large databases. Hypertension 2012; 60(2): 369-77.
[8]
Omboni S, Posokhov IN, Rogoza AN. Relationships between 24-h blood pressure variability and 24-h central arterial pressure, pulse wave velocity and augmentation index in hypertensive patients. Hypertens Res 2017; 40(4): 385-91.
[9]
Zhou TL, Henry RMA, Stehouwer CDA, van Sloten TT, Reesink KD, Kroon AA. Blood pressure variability, arterial stiffness, and arterial remodeling. Hypertension 2018; 72(4): 1002-10.
[10]
Shimbo D, Shea S, McClelland RL, et al. Associations of aortic distensibility and arterial elasticity with long-term visit-to-visit blood pressure variability: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Hypertens 2013; 26(7): 896-902.
[11]
Nagai M, Hoshide S, Ishikawa J, Shimada K, Kario K. Visit-to-visit blood pressure variations: new independent determinants for carotid artery measures in the elderly at high risk of cardiovascular disease. J Am Soc Hypertens 2011; 5(3): 184-92.
[12]
Okada R, Okada A, Okada T, Nanasato M, Wakai K. Visit-to-visit blood pressure variability is a marker of cardiac diastolic function and carotid atherosclerosis. BMC Cardiovasc Disord 2014; 14: 188.
[13]
Nagai M, Dote K, Kato M, et al. Visit-to-visit BP variability, average BP level and carotid arterial stiffness in the elderly: Results from a prospective study. J Hum Hypertens 2017; 31: 292-8.
[14]
Tedla YG, Yano Y, Carnethon M, Greenland P. Association between long-term blood pressure variability and 10-year progression in arterial stiffness: The Multiethnic Study of Atherosclerosis. Hypertension 2017; 69(1): 118-27.
[15]
Song H, Wei F, Liu Z, et al. Visit-to-visit variability in systolic blood pressure: correlated with the changes of arterial stiffness and myocardial perfusion in on-treated hypertensive patients. Clin Exp Hypertens 2015; 37(1): 63-9.
[16]
Nagai M, Dote K, Kato M, Sasaki S, Oda N. Visit-to-visit blood pressure variability: An epiphenomenon or a risk for the progression of carotid artery remodelling? Eur Heart J Cardiovasc Pharmacother 2017; 3(2): 90.
[17]
Okada H, Fukui M, Tanaka M, et al. Visit-to-visit variability in systolic blood pressure is a novel risk factor for the progression of coronary artery calcification. Hypertens Res 2013; 36(11): 996-9.
[18]
Kim JS, Park S, Yan P, Jeffers BW, Cerezo C. Effect of inter-individual blood pressure variability on the progression of atherosclerosis in carotid and coronary arteries: A post hoc analysis of the NORMALISE and PREVENT studies. Eur Heart J Cardiovasc Pharmacother 2017; 3(2): 82-9.
[19]
Aoyama R, Takano H, Suzuki K, et al. The impact of blood pressure variability on coronary plaque vulnerability in stable angina: An analysis using optical coherence tomography. Coron Artery Dis 2017; 28(3): 225-31.
[20]
Kawai T, Ohishi M, Ito N, et al. Alteration of vascular function is an important factor in the correlation between visit-to-visit blood pressure variability and cardiovascular disease. J Hypertens 2013; 31(7): 1387-95.
[21]
Lau KK, Wong YK, Chan YH, et al. Visit-to-visit blood pressure variability as a prognostic marker in patients with cardiovascular and cerebrovascular diseases--relationships and comparisons with vascular markers of atherosclerosis. Atherosclerosis 2014; 235(1): 230-5.
[22]
Mancia G, Facchetti R, Parati G, Zanchetti A. Visit-to-visit blood pressure variability, carotid atherosclerosis, and cardiovascular events in the European Lacidipine Study on Atherosclerosis. Circulation 2012; 126(5): 569-78.
[23]
Crouse JR, Goldbourt U, Evans G, et al. Risk factors and segment-specific carotid arterial enlargement in the Atherosclerosis Risk in Communities (ARIC) cohort. Stroke 1996; 27(1): 69-75.
[24]
Whisnant JP, Homer D, Ingall TJ, Baker HL Jr, O’Fallon WM, Wievers DO. Duration of cigarette smoking is the strongest predictor of severe extracranial carotid artery atherosclerosis. Stroke 1990; 21(5): 707-14.
[25]
Szirmai IG, Kamondi A, Magyar H, Juhász C. Relation of laboratory and clinical variables to the grade of carotid atherosclerosis. Stroke 1993; 24(12): 1811-6.
[26]
Sander D, Kukla C, Klingelhöfer J, Winbeck K, Conrad B. Relationship between circadian blood pressure patterns and progression of early carotid atherosclerosis: A 3-year follow-up study. Circulation 2000; 102(13): 1536-41.
[27]
Lorenz MW, Polak JF, Kavousi M, et al. Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): A meta-analysis of individual participant data. Lancet 2012; 379(9831): 2053-62.
[28]
van Sloten TT, Schram MT, van den Hurk K, et al. Local stiffness of the carotid and femoral artery is associated with incident cardiovascular events and all-cause mortality: the Hoorn study. J Am Coll Cardiol 2014; 63(17): 1739-47.
[29]
Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001; 37(5): 1236-41.
[30]
van Popele NM, Grobbee DE, Bots ML, et al. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke 2001; 32(2): 454-60.
[31]
Pringle E, Phillips C, Thijs L, et al. Systolic blood pressure variability as a risk factor for stroke and cardiovascular mortality in the elderly hypertensive population. J Hypertens 2003; 21(12): 2251-7.
[32]
Wang JG, Yan P, Jeffers BW. Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials. J Am Soc Hypertens 2014; 8(5): 340-9.
[33]
Wang JG, Staessen JA, Li Y, et al. Carotid intima-media thickness and antihypertensive treatment: A meta-analysis of randomized controlled trials. Stroke 2006; 37(7): 1933-40.
[34]
Higashihara T, Nagai M, Dote K, et al. Exaggerated coronary intimal thickening: An optical coherence tomography finding in myocardial bridge with concomitant spasm. Coron Artery Dis 2019; 30: 234-6.
[35]
Ichihara A, Kaneshiro Y, Takemitsu T, Sakoda M. Effects of amlodipine and valsartan on vascular damage and ambulatory blood pressure in untreated hypertensive patients. J Hum Hypertens 2006; 20(10): 787-94.
[36]
Rothwell PM. Limitations of the usual blood pressure hypothesis and importance of variability, instability, and episodic hypertension. Lancet 2010; 375: 938-48.
[37]
Shi R, Liu K, Shi D, Liu Q, Chen X. Effects of amlodipine and valsartan on blood pressure variability and pulse wave velocity in hypertensive patients. Am J Med Sci 2017; 353(1): 6-11.
[38]
Matsui Y, O’Rourke MF, Hoshide S, Ishikawa J, Shimada K, Kario K. Combined effect of angiotensin II receptor blocker and either a calcium channel blocker or diuretic on day-by-day variability of home blood pressure: the Japan Combined Treatment With Olmesartan and a Calcium-Channel Blocker Versus Olmesartan and Diuretics Randomized Efficacy Study. Hypertension 2012; 59(6): 1132-8.
[39]
Rakugi H, Ogihara T, Saruta T, et al. Preferable effects of olmesartan/calcium channel blocker to olmesartan/diuretic on blood pressure variability in very elderly hypertension: COLM study subanalysis. J Hypertens 2015; 33(10): 2165-72.
[40]
Sato N, Saijo Y, Sasagawa Y, et al. Visit-to-visit variability and seasonal variation in blood pressure: Combination of Antihypertensive Therapy in the Elderly, Multicenter Investigation (CAMUI) Trial subanalysis. Clin Exp Hypertens 2015; 37(5): 411-9.
[41]
Kingwell BA, Cameron JD, Gillies KJ, Jennings GL, Dart AM. Arterial complflex function in athletes and hypertensives. Am J Physiol 1995; 268(1 Pt 2): H411-8.
[42]
Watson RD, Stallard TJ, Flinn RM, Littler WA. Factors determining direct arterial pressure and its variability in hypertensive man. Hypertension 1980; 2(3): 333-41.
[43]
O’Rourke MF. Basic concepts for the understanding of large arteries in hypertension. J Cardiovasc Pharmacol 1985; 7(Suppl. 2): S14-21.


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 25
ISSUE: 6
Year: 2019
Page: [685 - 692]
Pages: 8
DOI: 10.2174/1381612825666190329122024
Price: $65

Article Metrics

PDF: 33
HTML: 8